Aims: We aim to analyze the data from our colposcopy clinic since its transition to the new cervical screening program to determine its effectiveness in clinical practice. 
Introduction
The new risk-based cervical screening program was who were tested with cytology only [1] . HPV 16 or 18 positive had been associated with increased incidence of CIN3 or worse up to 10 years later when cervical abnormalities were left untreated [2] . HPV 16, 18 and 45 accounted for 94% of HPV-related cervical cancers [3] . Studies had shown that HPV 16 and 18 were associated with CIN that were more likely to progress than regress [4] [5] .
Aim
The 
Materials and Methods
Data were extracted from the hospital's electronic medical records and analyzed by the bio-statistician.
Different associations and concordance were calculated and analyzed. The analyses were conducted in the R program using epi.R package [6] . Two by two tables, chi-squared tests, odds ratio with 95% confidence interval were computed from the observed count data and presented.
Result
Women referred to our colposcopy clinics had their cervical screening in different laboratories using HPV- Table 1 Table 2 ). The When compared to other HPV types, HPV Other accounted for the highest proportion of abnormal referred LBC, both high and low grades in our study (see Table 4 Table 6 ).
There was a moderately strong correlation between the referred LBC result and colposcopic impression (Cramer' s V= 0.29). The odds ratio for a high-grade colposcopic impression with a high-grade referring LBC Preliminary data from the PRINCess trial suggests there is a 43% likelihood of regression of CIN 2 in women below age of 25 [7] . A study evaluating cervical screening in 4767 women under 25 years old showed that only 63 women (2.5%) had CIN 2-3 confirmed on LLETZ. This study concluded that screening women under the age of 25 may cause unnecessary referral to colposcopy and subjecting women to anxiety and psychosocial morbidity [8] . Till more evidence is available, the management of high-grade cervical abnormalities for women aged 25 is controversial, largely due to limited data around safety and benefit in this group. A total number of 168 patients were biopsied in our colposcopy clinic. For the purposes of data comparison, we grouped cervicitis, inflammation, HPV % within Colp Impression 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% (unsatisfactory and glandular have been removed so n=255) 
Discussion
One pre-cancerous changes, followed by 16, 58, 39, 18, and 56 [10] . In another study, it is estimated that the prevalence of HPV Other (non 16/18) is three times higher than HPV 16/18 [11] . In a Sydney-based study, in the CIN 2-3 category [17] . The colposcopy-biopsy concordance in our high-grade abnormal group is a mere 47%, which is lower than quoted other literature.
Only given that women were previously vaccinated with the Cervarix and quadrivalent Gardasil vaccine, which do not cover for the other oncogenic HPV types.
